Eli Lilly Pledges $3 Billion to China as Beijing Presses for Bigger Commitment
Eli Lilly has unveiled a $3 billion investment plan for China over the next decade, focused largely on local production of its experimental weight-loss pill orforglipron. Chinese Commerce Minister Wang Wentao urged the company to increase its commitment and pursue more ambitious growth targets, citing recent trade talks in Paris as a positive devel…